Gonal-F®
Sponsors
Merck KGaA, Darmstadt, Germany, Dong-A ST Co., Ltd., Gema Biotech S.A., Merckle GmbH, Assistance Publique - Hôpitaux de Paris
Conditions
AnovulationAssisted Reproductive TechniquesBioequivalenceFertilityFollicle Stimulating Hormone DeficiencyIn-Vitro FertilizationInfertilityInfertility, Female
Phase 1
Study to Compare the Bioavailability, Safety and Tolerability of XM17 in Healthy, Down Regulated Young Women
CompletedNCT02592031
Start: 2009-02-28End: 2009-12-31Updated: 2021-11-09
Study on the Safety and Pharmacokinetics of LM001 and Gonal-F® in Healthy Women
NCT03535103
Start: 2018-06-01End: 2019-12-31Target: 32Updated: 2018-05-29
Study on the Pharmacokinetics and Safety of QL1012D and Gonal-F® in Healthy Female Volunteers
Active, not recruitingNCT06864793
Start: 2025-04-06End: 2026-04-01Target: 48Updated: 2026-02-17
Phase 3
Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro Fertilization
CompletedNCT01183143
Start: 2004-05-11End: 2006-03-02Updated: 2018-04-06
PERgoveriS In Stratified Treatment for Assisted Reproductive Technique
CompletedNCT01297465
Start: 2011-05-31End: 2012-10-31Updated: 2021-05-28
A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique
TerminatedNCT01497197
Start: 2012-05-31End: 2014-01-31Updated: 2015-11-09
A Phase III Clinical Study to Compare the Efficacy and Safety of DA-3801 and That of Gonal-F®
CompletedNCT01820728
Start: 2007-01-31End: 2012-10-31Updated: 2021-04-15
Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART)
CompletedNCT02047227
Start: 2014-01-31End: 2015-08-31Updated: 2017-08-24
A Randomized, Multicentre, Open Label, Evaluator Blinded Study to Evaluate Safety and Efficacy of Folitime® of Gemabiotech S.A., Versus Gonal-f ® of Merck Serono, in Patients With Infertility Undergoing ART
CompletedNCT02454556
Start: 2015-04-30End: 2016-12-31Updated: 2017-02-24